Taken together, our present study demonstrates that tumorous IRE1α facilitates anti-cancer immunosurveillance and improves immunotherapy efficacy in melanoma via the regulation of chemokines, cytokines and PD-L1 expression. The gene discussed is CD274; the disease is melanoma.